(2016/06) Effects of long-term folate supplementation on metabolic status and regression of cervical intraepithelial neoplasia: A randomized, double-blind, placebo-controlled trial.

(2016/04) Association between serum folate level and cervical cancer: a meta-analysis.

(2014/11) Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation associated risk of developing higher grades of CIN.

(2010/08) Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs).

(2009/10) Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.

(2009/07) Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.

(2003/11) Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12.

(2021/06) Anti-Influenza with Green Tea Catechins: A Systematic Review and Meta-Analysis.

(2011/03) Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis.

(2008/06) Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial.

(2003/10) Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions.

(2006/03) A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia.

(2000/08) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.

(2003/05) Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States).

(2015/10) The favourable effects of long-term selenium supplementation on regression of cervical tissues and metabolic profiles of patients with cervical intraepithelial neoplasia: a randomised, double-blind, placebo-controlled trial.

(2010/04) Dietary supplements reduce the risk of cervical intraepithelial neoplasia.

(2010/02) Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea.

(2011/10) Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis.

(2010/08) Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs).

(2009/07) Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.

(2003/11) Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12.

(2016/01) Association between vitamin C Intake and the risk of cervical neoplasia: A meta-analysis.

(2011/10) Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis.

(2010/04) Dietary supplements reduce the risk of cervical intraepithelial neoplasia.

(2010/02) Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea.

(2017/02) Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.

(2016/06) Association Between Serum 25-Hydroxyvitamin D Level and Human Papillomavirus Cervicovaginal Infection in Women in the United States.

(2017/08) Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies.

(2011/10) Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis.

(2010/04) Dietary supplements reduce the risk of cervical intraepithelial neoplasia.

(2010/02) Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea.

(2019/08) Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study.

(2019/06) Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis.

(2017/04) The Clinical Significance of Endocannabinoids in Endometriosis Pain Management.

(2017/04) Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis.

(2011/05) Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study.

(2017/05) Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study.

(2013/04) Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia?

(2009/05) Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.

(2002/03) An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome.

(2015/12) Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.

(2019/11) Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients With Interstitial Cystitis/Bladder Pain Syndrome.

(2020/09) Maternal choline and respiratory coronavirus effects on fetal brain development.

(2019/05) Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development.

(2017/12) The effect of fish oil supplementation on maternal and neonatal outcomes: a triple-blind, randomized controlled trial.

(2016/03) Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies.

(2016/01) Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials.

(2015/08) The Effect of Omega-3 Docosahexaenoic Acid Supplementation on Gestational Length: Randomized Trial of Supplementation Compared to Nutrition Education for Increasing n-3 Intake from Foods.

(2012/06) Determinants of DHA levels in early infancy: differential effects of breast milk and direct fish oil supplementation.

(2011/07) Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age.

(2011/07) High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes.

(2010/12) Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants

(2010/12) Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development

(2010/08) Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants

(2010/02) The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid.

(2005/10) Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants

(2005/08) Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life

(2004/03) Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes

(2020/12) Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health.

(2019/07) The Effect of High-Dose Postpartum Maternal Vitamin D Supplementation Alone Compared with Maternal Plus Infant Vitamin D Supplementation in Breastfeeding Infants in a High-Risk Population. A Randomized Controlled Trial.

(2018/09) Maternal Supplementation of Vitamin D during Lactation to Support Infant Vitamin D Needs: A Systematic Review.

(2018/01) A Longitudinal Study of 25-Hydroxy Vitamin D and Parathyroid Hormone Status throughout Pregnancy and Exclusive Lactation in New Zealand Mothers and Their Infants at 45° S.

(2016/01) Vitamin D content in human breast milk: a 9-mo follow-up study.

(2015/08) Maternal vitamin D₃ supplementation at 50 μg/d protects against low serum 25-hydroxyvitamin D in infants at 8 wk of age: a randomized controlled trial of 3 doses of vitamin D beginning in gestation and continued in lactation.

(2015/10) Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial.

(2014/09) Impact of vitamin D supplementation during lactation on vitamin D status and body composition of mother-infant pairs: a MAVID randomized controlled trial.

(2010/07) Circulating 25-hydroxyvitamin d levels in fully breastfed infants on oral vitamin d supplementation.

(2010/01) Use of supplemental vitamin d among infants breastfed for prolonged periods.

(2009/04) Vitamin D requirements in the first year of life

(2009/01) Effect of combined maternal and infant vitamin D supplementation on vitamin D status of exclusively breastfed infants.

(2008/11) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents

(2007/06) Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women.

(2006/07) High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study.

(2006/04) The effect of high-dose vitamin D supplementation on serum vitamin D levels and milk calcium concentration in lactating women and their infants

(2004/12) Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant.

(2021/03) Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview.

(2016/06) Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.

(2016/06) Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints.

(2015/04) Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review.

(2013/12) Phytoestrogens for menopausal vasomotor symptoms.

(2012/07) Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.

(2011/07) Soy extracts versus hormone therapy for reduction of menopausal hot flushes: indirect comparison.

(2011/05) The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index.

(2011/02) Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women.

(2010/11) The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial.

(2009/05) Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.

(2009/03) Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.

(2008/07) Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones.

(2007/11) Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.

(2007/10) Phytoestrogens for vasomotor menopausal symptoms.

(2007/07) Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.

(2006/10) Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis.

(2006/09) Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies.

(2003/03) Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency.

(2002/03) Benefits of soy isoflavone therapeutic regimen on menopausal symptoms.

(2024/03) The Effects of Vitamin D Supplementation on C-Reactive Protein and Systolic and Diastolic Blood Pressure in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.

(2023/11) Effect of non-pharmacological interventions on the prevention of sarcopenia in menopausal women: a systematic review and meta-analysis of randomized controlled trials.

(2015/03) Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind,placebo-controlled trial.

(2015/10) Effect of vitamin D supplementation alone on muscle function in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial.

(2015/10) Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled Trial.

(2015/03) Serum 25 Hydroxyvitamin D, Bone Mineral Density and Fracture Risk Across the Menopause.

(2011/06) Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

(2023/04) Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis.

(2022/01) The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.

(2021/01) The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.

(2019/02) Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome.

(2018/03) The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome.

(2017/04) The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

(2022/11) Effect of Curcumin on Glycaemic and Lipid Parameters in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

(2022/08) Curcumin and Polycystic Ovary Syndrome: a Systematic Review.

(2022/01) The effects of curcumin as dietary supplement for patients with polycystic ovary syndrome: An updated systematic review and meta-analysis of randomized clinical trials.

(2021/09) Potential Health Benefits of Curcumin on Female Reproductive Disorders: A Review.

(2021/04) Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial.

(2021/02) Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis.

(2021/01) Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial.

(2020/04) Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.

(2020/03) The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial.

(2019/12) The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.

(2023/01) Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

(2022/01) Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study.

(2022/01) Role of Myo-inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Teenage Girls affected by PCOS: A Prospective Cohort Study.

(2021/05) High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries.

(2020/09) Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial.

(2019/06) The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.

(2019/03) Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome.

(2019/01) Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials.

(2019/01) Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.

(2018/07) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.

(2018/02) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials.

(2017/11) Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.

(2017/08) Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial.

(2017/06) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.

(2017/05) Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study.

(2017/01)Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).

(2016/10) Inositol Treatment and ART Outcomes in Women with PCOS

(2016/08)Myo-Inositol in the Treatment of Teenagers Affected by PCOS.

(2016/08) Prospective Randomized Study on the Influence of Myoinositol in PCOS Women Undergoing IVF in the Improvement of Oocyte Quality, Fertilization Rate, and Embryo Quality.

(2016/07) A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.

(2015/12) Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.

(2015/08) Inositol versus Metformin administration in polycystic ovary syndrome patients: a case–control study

(2015/07) Reflections on inositol(s) for PCOS therapy: steps toward success.

(2015/02) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance

(2014/10) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.

(2014/05) Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome.

(2014/03) Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.

(2013/12) The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.

(2013/04) Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.

(2013/02) The combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.

(2012/05) The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.

(2012/02) Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition.

(2011/05) Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.

(2011/04) Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

(2010/04) Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.

(2009/08) Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.

(2009/05) Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

(2009/03) Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.

(2007/09) Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.

(2021/06) Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

(2018/02) Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study.

(2016/01) Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.

(2023/09) Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome.

(2023/03) Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

(2021/08) Efficacy of omega-3 polyunsaturated fatty acids on hormones, oxidative stress, and inflammatory parameters among polycystic ovary syndrome: a systematic review and meta-analysis.

(2018/03) Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis.

(2017/06) The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome.

(2017/05) Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome.

(2013/08) The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial.

(2013/04) Efficacy of omega-3 in the treatment of polycystic ovary syndrome.

(2012/12) Benefits of Omega-3 Fatty Acids Supplementation on Serum Paraoxonase 1 Activity and Lipids Ratios in Polycystic Ovary Syndrome.

(2012/10) Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome.

(2021/02) The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

(2020/12) Vitamin D Supplementation Ameliorates Metabolic Dysfunction in Patients with PCOS: A Systematic Review of RCTs and Insight into the Underlying Mechanism.

(2020/04) Effect of vitamin D supplementation on polycystic ovary syndrome: A meta-analysis.

(2019/01) A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

(2018/04) The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

(2017/12) The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.

(2017/11) Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.

(2017/08) Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

(2017/03) The Effect of Vitamin D Supplementation on the Androgenic Profile in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.

(2017/02) Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.

(2015/10) Vitamin D Supplementation Decreases TGF-?1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial

(2014/06) High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.

(2022/07) Evidence based recommendations for an optimal prenatal supplement for women in the US: vitamins and related nutrients.

(2021/05) Evidence-Based Recommendations for an Optimal PrenatalSupplement for Women in the U.S., Part Two: Minerals.

(2014/12) Pregnancy and lactation alter biomarkers of biotin metabolism in women consuming a controlled diet.

(2009/01) Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice.

(2002/02) Marginal biotin deficiency during normal pregnancy

(2016/01) The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia

(2021/12) Choline metabolome response to prenatal choline supplementation across pregnancy: A randomized controlled trial.

(2020/09) Maternal choline and respiratory coronavirus effects on fetal brain development.

(2020/01) Choline: The Neurocognitive Essential Nutrient of Interest to Obstetricians and Gynecologists.

(2019/05) Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development.

(2018/07) Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

(2018/01) Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study.

(2017/01) Genetic Variation in Choline-Metabolizing Enzymes Alters Choline Metabolism in Young Women Consuming Choline Intakes Meeting Current Recommendations.

(2016/10) Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis.

(2016/01) Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.

(2013/06) Choline intake during pregnancy and child cognition at age 7 years.

(2012/11) Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function: a randomized, double-blind, placebo-controlled trial.

(2012/05) Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans.

(2010/08) Pre- and postnatal health: evidence of increased choline needs.

(2009/09) Choline and risk of neural tube defects in a folate-fortified population

(2009/02) Importance of methyl donors during reproduction

(2006/11) The fetal origins of memory: the role of dietary choline in optimal brain development

(2006/04) Perinatal choline influences brain structure and function

(2004/07) Periconceptional dietary intake of choline and betaine and neural tube defects in offspring

(2009/04) Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia.

(2022/10) Folic acid versus 5- methyl tetrahydrofolate supplementation in pregnancy.

(2022/09) Folate Insufficiency Due to MTHFR Deficiency Is Bypassed by 5-Methyltetrahydrofolate.

(2021/09) Comparative Study between the Use of Regular Folic Acid Supplement versus the Use of L-Methyl Folate in Patients with Methyl Tetrahydrofolate Reductase (MTHFR) Gene Mutation with Recurrent Pregnancy Loss.

(2020/11) Pharmacokinetics of Sodium and Calcium Salts of (6S)-5-Methyltetrahydrofolic Acid Compared to Folic Acid and Indirect Comparison of the Two Salts.

(2020/10) Folic acid versus 5-methyl tetrahydrofolate supplementation in pregnancy.

(2020/09) Folate Insufficiency Due to MTHFR Deficiency Is Bypassed by 5-Methyltetrahydrofolate.

(2017/12) Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects.

(2016/12) Effects of folic acid supplementation during different pregnancy periods and relationship with the other primary prevention measures to neural tube defects.

(2015/10) Folic acid supplementation and dietary folate intake, and risk of preeclampsia.

(2015/12) Effects and safety of periconceptional oral folate supplementation for preventing birth defects.

(2013/03) Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects?

(2012/07) Maternal intake of methyl-donor nutrients and child cognition at 3 years of age.

(2012/01) The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood.

(2011/10) Folic acid supplements in pregnancy and severe language delay in children.

(2011/06) Policy statement on folic acid and neural tube defects.

(2010/10) Effects and safety of periconceptional folate supplementation for preventing birth defects

(2010/08) Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.

(2009/05) Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force

(2006/07) Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age.

(2006/04) [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation.

(2004/03) Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women.

(1991/07) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

(2023/06) Inositol supplementation for the prevention and treatment of gestational diabetes mellitus: a meta-analysis of randomized controlled trials.

(2022/06) Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes.

(2019/01) Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.

(2018/09) Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.

(2018/03) Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.

(2018/02) The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials.

(2017/06) The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.

(2016/10) Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.

(2015/12) Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.

(2015/10) Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis.

(2015/08) Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.

(2013/07) Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.

(2013/04) Myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.

(2012/06) Myo-inositol may prevent gestational diabetes in PCOS women.

(2011/08) The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes.

(2018/07) Iodine status during pregnancy and lactation: a pilot study in the Netherlands.

(2016/09) Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns.

(2013/11) Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials.

(2011/12) Iodine nutrition in pregnancy and lactation.

(2011/09) Dietary iodine in pregnancy and postpartum.

(2011/04) Effect of iodine supplementation during pregnancy on infant neurodevelopment at 1 year of age.

(2010/11) The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed.

(2010/06) Some Subgroups of Reproductive Age Women in the United States May Be at Risk for Iodine Deficiency

(2009/09) Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life.

(2009/05) Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation.

(2009/02) Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review

(2007/12) Iodine deficiency and brain development in the first half of pregnancy

(2007/12) The prevalence of iodine deficiency in women of reproductive age in the United States of America

(2007/09) The adverse effects of mild-to-moderate iodine deficiency during pregnancy and childhood: a review

(2006/10) Iodine supplementation for pregnancy and lactation-United States and Canada: recommendations of the American Thyroid Association

(2024/02) Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.

(2022/07) A dose-response meta-analysis of the association between the maternal omega-3 long-chain polyunsaturated fatty acids supplement and risk of asthma/wheeze in offspring.

(2017/03) The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes.

(2016/10) Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial.

(2016/09) The effect of prenatal docosahexaenoic acid supplementation on infant outcomes in African American women living in low-income environments: A randomized, controlled trial.

(2015/11) Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies.

(2013/04) DHA supplementation and pregnancy outcomes.

(2012/03) Omega-3 fatty acids and pregnancy: current implications for practice.

(2012/01) Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial.

(2011/08) Prenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial.

(2011/08) Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and meta-analysis.

(2011/08) Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review.

(2011/07) The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review.

(2011/06) Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial.

(2011/04) Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort.

(2010/10) Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial

(2010/10) Effects of n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation during Pregnancy and/or Lactation on Neurodevelopment and Visual Function in Children: A Systematic Review of Randomized Controlled Trials.

(2009/12) Atopy Risk in Infants and Children in Relation to Early Exposure to Fish, Oily Fish, or Long-Chain Omega-3 Fatty Acids: A Systematic Review

(2008/01) Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial

(2007/12) The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial

(2007/08) Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil

(2007/08) Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials

(2007/06) Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy?

(2007/06) Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo

(2003/12) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.

(2003/01) Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age

(2023/01)The effects of pyridoxine (vitamin B6) supplementation in nausea and vomiting during pregnancy: a systematic review and meta-analysis.

(2012/03) Vitamin B6 supplementation in pregnant women with nausea and vomiting.

(2010/09) Interventions for nausea and vomiting in early pregnancy.

(1995/09) Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial

(1991/07) Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study

(2023/11) Vitamin D Status as an Important Predictor of Preterm Birth in a Cohort of Black Women.

(2022/07) Vitamin D and miscarriage: a systematic review and meta-analysis.

(2022/07) Effects of vitamin D supplementation during pregnancy on offspring health at birth: A meta-analysis of randomized controlled trails.

(2022/06) Association between serum vitamin D level during pregnancy and recurrent spontaneous abortion: a systematic review and meta-analysis.

(2021/12) High-dose vitamin D supplementation in pregnancy and 25(OH)D sufficiency in childhood reduce the risk of fractures and improve bone mineralization in childhood: Follow-up of a randomized clinical trial.

(2019/04) Vitamin D status during pregnancy and the risk of gestational diabetes mellitus: A longitudinal study in a multiracial cohort.

(2018/01) Maternal Vitamin D Status and Risk of Gestational Diabetes: a Meta-Analysis.

(2018/01) Maternal early pregnancy vitamin D status in relation to low birth weight and small-for-gestational-age offspring.

(2017/11) Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials.

(2017/10) Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials.

(2017/09) Meta-analysis of the effect of the maternal vitamin D level on the risk of spontaneous pregnancy loss.

(2017/07) Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center.

(2015/10) Vitamin D status is inversely associated with anemia and serum erythropoietin during pregnancy.

(2015/01) Typical Prenatal Vitamin D Supplement Intake Does Not Prevent Decrease of Plasma 25-Hydroxyvitamin D at Birth

(2014/12) Dietary Fat Increases Vitamin D-3 Absorption.

(2014/07) Association Between Sex Steroids, Ovarian Reserve, and Vitamin D Levels in Healthy Nonobese Women

(2013/07) Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis.

(2013/03) Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies.

(2013/02) A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina.

(2012/09) Vitamin D deficiency in pregnancy and gestational diabetes mellitus.

(2012/08) Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants.

(2012/07) Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women.

(2012/05) Association of low serum 25-Hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes.

(2012/04) Maternal vitamin D status and delivery by cesarean.

(2012/03) Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development.

(2012/03) Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia.

(2012/02) Vitamin D supplementation for women during pregnancy.

(2012/01) Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring.

(2011/12) Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy.

(2011/12) Vitamin D status during pregnancy: maternal, fetal, and postnatal outcomes.

(2011/10) Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness.

(2011/09) Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy.

(2011/06) Maternal vitamin D and fetal growth in early-onset severe preeclampsia.

(2011/06) Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis.

(2011/01) Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma.

(2011/01) Vitamin D deficiency and insufficiency is common during pregnancy.

(2011/01) Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis.

(2010/12) Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia.

(2010/12) Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia

(2010/11) A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia

(2010/10) First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

(2010/05) Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States.

(2010/05) Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women

(2010/01) Low maternal vitamin D status and fetal bone development: cohort study.

(2009/09) Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study.

(2009/06) Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy

(2009/05) Vitamin D deficiency and supplementation during pregnancy

(2009/04) Vitamin D intake during pregnancy: association with maternal characteristics and infant birth weight

(2009/03) Association between Vitamin D Deficiency and Primary Cesarean Section

(2008/03) Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus

(2007/02) High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates

(2006/01) Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study.

(2023/10) Cranberry Supplements for Urinary Tract Infection Prophylaxis in Pregnant Women: A Systematic Review of Clinical Trials and Observational Studies on Efficacy, Acceptability, Outcomes Measurement Methods, and Studies' Feasibility.

(2023/04) Cranberries for preventing urinary tract infections.

(2019/05) Recurrent Uncomplicated Urinary Tract Infections In Women: AUA/CUA/SUFU Guideline.

(2018/10) Cranberry Standardized Capsules May Prevent Recurrences of Urinary Tract Infections in Children.

(2017/12) Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis.

(2017/09) Can Cranberries Contribute to Reduce the Incidence of Urinary Tract Infections? A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Clinical Trials.

(2016/11) Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial.

(2016/09) Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: a randomized placebo-controlled clinical research study.

(2016/06) Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection.

(2015/12) Cranberry Products for the Prophylaxis of Urinary Tract Infections in Pediatric Patients.

(2015/08) Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial.

(2015/01) Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study.

(2014/01) Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: a double-blind randomized placebo-controlled trial in long-term care facilities.

(2012/10) Cranberries for preventing urinary tract infections.

(2012/07) Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials.

(2011/06) Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin

(2011/01) Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial

(2009/07) Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration

(2009/02) Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women

(2008/10) Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study.

(2007/06) Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells.

(2007/04) Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial.

(2006/02) Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial.

(2005/11) Inhibition of uropathogenic Escherichia coli by cranberry juice: a new antiadherence assay.

(2005/09) A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity.

(2005/05) Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial.

(2002/06) A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women.

(2001/06) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.

(1998/10) Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries.

(2023/03) D-Mannose for Recurrent Urinary Tract Infection Prevention in Postmenopausal Women Using Vaginal Estrogen: A Randomized Controlled Trial.

(2022/08) D-mannose for preventing and treating urinary tract infections.

(2022/03) Recurrent Urinary Tract Infection Incidence Rates Decrease in Women With Cystitis Cystica After Treatment With d-Mannose: A Cohort Study.

(2022/02) Why D-Mannose May Be as Efficient as Antibiotics in the Treatment of Acute Uncomplicated Lower Urinary Tract Infections-Preliminary Considerations and Conclusions from a Non-Interventional Study.

(2021/04) Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives.

(2020/08) D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis.

(2016/07) D-mannose: a promising support for acute urinary tract infections in women. A pilot study.

(2014/02) D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial.

(2014/01) Oral D-mannose in recurrent urinary tract infections in women: a pilot study.